You are here: vision-research.eu » People » Research Groups » United Kingdom » Coupland, Sarah

Liverpool Ocular Oncology Research Group (LOORG)

The Liverpool Ocular Oncology Research Group’s (LOORG’s) mission is to conduct high quality basic, translational and clinical research into the pathogenesis and treatment of adult ocular tumours that will improve patient care and survival. The Liverpool Ocular Oncology Research Group (LOORG) was established by Professor Sarah Coupland and Professor Bertil Damato in 2006. Prof. Coupland has since lead the basic science and translational research portfolio, in addition to being a Consultant Pathologist at the Royal Liverpool University Hospital.

A major strength of the LOORG is the close collaboration between ocular oncology clinicians (Lead, Professor Heimann), pathologists and basic scientists (Dr Sarah Lake and Dr Helen Kalirai) which ensures that the research we conduct addresses the key questions that will bring about improved survival and quality of life for ocular oncology patients.

Group Leader

Sarah E. Coupland
[more information]

Contact

University of Liverpool

Molecular and Clinical Cancer Medicine
Institute of Translational Medicine
6th Floor, Duncan Building
L69 3GA Liverpool
United Kingdom

Phone: +44(0)151 706 4494
Fax: +44(0)151 706 5826

E-mail:
s.e.coupland[at]liverpool.ac.uk

Website:
www.loorg.org

Current Research Projects

  • Project 1:
    Identification of regulators of metastasis in uveal melanoma
  • Project 2:
    Proteomic discovery of serum biomarkers in metastatic uveal melanoma
  • Project 3:
    Estimating survival prognosis after treatment of choroidal melanoma
  • Project 4:
    Gross chromosomal abnormalities in iris melanoma
  • Project 5:
    Molecular characteristics of metastatic liver lesions in uveal melanoma: the search for therapeutic targets

Research Groups

People

Related Research Groups

clinical laboratory testing
Oops, an error occurred! Code: 2018121100150423a91722
conjunctiva
Oops, an error occurred! Code: 201812110015048aef21e4
disease gene mapping
Oops, an error occurred! Code: 20181211001504f8d7b332
gene/expression
Oops, an error occurred! Code: 20181211001504d4d8ab82
gene microarray
Oops, an error occurred! Code: 20181211001504d31d5745
genetics
Oops, an error occurred! Code: 20181211001504fe9ea040
immunohistochemistry
Oops, an error occurred! Code: 2018121100150460577489
iris
Oops, an error occurred! Code: 20181211001504d3f86930
melanoma
Oops, an error occurred! Code: 201812110015040dba06ed
oncology
Oops, an error occurred! Code: 2018121100150473576461
pathology: experimental
Oops, an error occurred! Code: 201812110015049e9a9d78
pathology: human
Oops, an error occurred! Code: 2018121100150474a9e069
pathology techniques
Oops, an error occurred! Code: 2018121100150454e3a8d7
tumors
Oops, an error occurred! Code: 2018121100150428ad935a
uvea
Oops, an error occurred! Code: 20181211001504295b370c
vision and action
Oops, an error occurred! Code: 20181211001504c546defa
visual acuity
Oops, an error occurred! Code: 201812110015049d3c0e68
uveal melanoma
Oops, an error occurred! Code: 20181211001504bd0a69e0
conjunctival melanoma
Oops, an error occurred! Code: 20181211001504a7351646
intraocular and ocular adnexal lymphomas
Oops, an error occurred! Code: 201812110015049dea8840
pathology
Oops, an error occurred! Code: 201812110015043e546d37
translational studies
Oops, an error occurred! Code: 20181211001504e9990344